The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.

Indigenous medical device and diagnostics market growing at 6% crosses Rs 36,000 crore

The market of indigenous medical device and diagnostics is worth Rs 36,400 crore growing at 6 per cent for 2018-19. Indian medical device and diagnostics market comprises of over 800 companies. The domestic medical devices market is highly fragmented with less than 100 companies generating a revenue of over Rs 50 crore per year. The growing demand for quality healthcare and the absence of matching delivery mechanisms pose a challenge and certainly a great opportunity.

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by MMA Media, 2019-12-05 01:11:06

BioSpectrum India December 2019

Indigenous medical device and diagnostics market growing at 6% crosses Rs 36,000 crore

The market of indigenous medical device and diagnostics is worth Rs 36,400 crore growing at 6 per cent for 2018-19. Indian medical device and diagnostics market comprises of over 800 companies. The domestic medical devices market is highly fragmented with less than 100 companies generating a revenue of over Rs 50 crore per year. The growing demand for quality healthcare and the absence of matching delivery mechanisms pose a challenge and certainly a great opportunity.

Keywords: pharma

Struggling with the filter validation in
your regulated drugs production process?

Bank on us.

Merck’s BioReliance® Validation Services (Formerly Provantage® Lab, Bangalore, India) received
clearance from the State Excise Department, Government of Karnataka - which enables us to carry
out Aseptic Filter Validation studies for narcotic drugs manufactured by pharmaceutical industry.
Which means you can rely on our experience to ensure you don’t
encounter delays or regulatory observations. Our local Validation
Coordinators possess intimate knowledge of regulations and industry
expectations to assist you in developing and implementing an
appropriate validation strategy.

Trust our global network for,

• Extractables and Leachables testing
• Bacterial retention testing
• Product based integrity test
• Compatibility testing
• Patient safety evaluations

Merck, the Vibrant M and BioReliance are registered trademark of Merck KGaA,
Darmstadt, Germany or its affiliates.
All other trademarks are the property of their respective owners. Detailed
information on trademarks is available via publicly accessible resources.
© 2019 Merck KGaA, Darmstadt, Germany and/or its affiliates.

The lifescience business
of Merck operates as
MilliporeSigma in U.S
and Canada

RNI No. DELENG/2004/13061 Published on 28th of previous month PCW/193/2017-2019
Posting Date: 30th of every month Posted at Ex Servicemen Colony PO, Pune-38


Click to View FlipBook Version